Wachtell, Lipton, Rosen & Katz has advised Pfizer. Skadden has advised Shionogi. Slaughter and May has advised GSK plc. GSK plc and Shionogi & Co., Ltd...
Shionogi Increases Stake in ViiV Healthcare Through $2.125 Billion Transaction with GSK and Pfizer
Shionogi Acquires Global Rights to RADICAVA Business from Tanabe Pharma Corporation for $2.5 Billion
Cleary Gottlieb Steen & Hamilton LLP has advised Shionogi & Co. Ltd. and Shionogi Inc.; Ropes & Gray LLP has advised Tanabe Pharma Corporation. Shionogi &...
Shionogi’s Joint Venture with Apnimed
A&O advised Shionogi on its strategic joint venture. Shionogi & Co., Ltd. (Shionogi) has recently entered into a strategic collaboration and formed a joint venture with...
Shionogi’s Acquisition of Qpex Biopharma
Cleary Gottlieb represented Shionogi Inc. in the transaction. Shionogi Inc., a New Jersey-based subsidiary of Shionogi & Co., Ltd. (Shionogi), announced its acquisition of Qpex Biopharma,...